Finivi Inc’s Thermo Fisher Scientific TMO Stock Holding History

Finivi Inc’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1.39M	Buy	+2,103	New	+$1.31M	1.47%	23

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Finivi Inc's TMO Position: Q4 2021 in Review

Finivi Inc opened a new position in Thermo Fisher Scientific (TMO) in Q4 2021: 2,103 shares worth $1.39M. The stake represents 1.47% of the portfolio and ranks #23 among its holdings.

2,343 funds tracked by Wall St. Rank hold TMO as of Q4 2021.

Finivi Inc held 2,103 shares of Thermo Fisher Scientific worth $1.39M as of Q4 2021.
Thermo Fisher Scientific was a new Finivi Inc position in Q4 2021.
Thermo Fisher Scientific made up 1.47% of Finivi Inc's portfolio in Q4 2021, its #23 holding.
2,343 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2021.

Based on Finivi Inc's 13F filing for Q4 2021, filed 19 Dec 2025.